BBA
Baker Bros. Advisors’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.6M | Hold |
4,633,838
| – | – | 0.51% | 23 |
|
|
2025
Q1 | $30.8M | Hold |
4,633,838
| – | – | 0.34% | 29 |
|
|
2024
Q4 | $51.1M | Buy |
4,633,838
+265,395
| +6% | +$2.93M | 0.55% | 25 |
|
|
2024
Q3 | $53.7M | Hold |
4,368,443
| – | – | 0.56% | 24 |
|
|
2024
Q2 | $59M | Buy |
4,368,443
+1,000,000
| +30% | +$13.5M | 0.75% | 21 |
|
|
2024
Q1 | $45.5M | Buy |
3,368,443
+1,338,309
| +66% | +$18.1M | 0.57% | 29 |
|
|
2023
Q4 | $10.7M | Buy |
2,030,134
+544,219
| +37% | +$2.86M | 0.12% | 45 |
|
|
2023
Q3 | $5.85M | Sell |
1,485,915
-644,323
| -30% | -$2.54M | 0.03% | 65 |
|
|
2023
Q2 | $22.6M | Buy |
2,130,238
+14,822
| +0.7% | +$158K | 0.13% | 40 |
|
|
2023
Q1 | $17.6M | Buy |
2,115,416
+1,006,503
| +91% | +$8.38M | 0.1% | 40 |
|
|
2022
Q4 | $10.2M | Buy |
1,108,913
+739,586
| +200% | +$6.83M | 0.06% | 57 |
|
|
2022
Q3 | $4.74M | Buy |
+369,327
| New | +$4.74M | 0.03% | 83 |
|